|
US5319071A
(en)
|
1987-11-25 |
1994-06-07 |
Immunex Corporation |
Soluble interleukin-1 receptors
|
|
WO1989004838A1
(en)
|
1987-11-25 |
1989-06-01 |
Immunex Corporation |
Interleukin-1 receptors
|
|
IE61148B1
(en)
|
1988-03-10 |
1994-10-05 |
Ici Plc |
Method of detecting nucleotide sequences
|
|
US5350683A
(en)
|
1990-06-05 |
1994-09-27 |
Immunex Corporation |
DNA encoding type II interleukin-1 receptors
|
|
US5645988A
(en)
|
1991-05-08 |
1997-07-08 |
The United States Of America As Represented By The Department Of Health And Human Services |
Methods of identifying drugs with selective effects against cancer cells
|
|
US5569582A
(en)
|
1991-07-15 |
1996-10-29 |
Institute Of Molecular Biology & Technology |
Rapid amplification and detection of nucleic acids
|
|
PE64396A1
(es)
|
1995-01-23 |
1997-01-28 |
Hoffmann La Roche |
Proteina accesoria del receptor de la interleucina 1
|
|
NZ505499A
(en)
|
1998-01-23 |
2002-07-26 |
Immunex Corp |
Accessory protein-like DNA and polypeptides
|
|
US20030148301A1
(en)
|
1999-12-10 |
2003-08-07 |
Toshiya Aono |
Method of detecting nucleotide polymorphism
|
|
DE60123448T2
(de)
|
2001-12-24 |
2007-08-23 |
Prof. Wolfgang Holzgreve |
Verfahren zur nicht-invasiven Diagnose von Transplantationen und Transfusionen
|
|
US6977162B2
(en)
|
2002-03-01 |
2005-12-20 |
Ravgen, Inc. |
Rapid analysis of variations in a genome
|
|
JP4116856B2
(ja)
|
2002-10-02 |
2008-07-09 |
富士フイルム株式会社 |
１塩基多型の検出方法
|
|
EP1599608A4
(en)
|
2003-03-05 |
2007-07-18 |
Genetic Technologies Ltd |
Identification of fetal DNA and fetal cell marker in maternal plasma or serum
|
|
JP2008501340A
(ja)
|
2004-06-02 |
2008-01-24 |
ニユー・イングランド・バイオレイブス・インコーポレイテツド |
ショットガン配列データからの機能推定
|
|
WO2006047481A2
(en)
|
2004-10-22 |
2006-05-04 |
Redpath Integrated Pathology, Inc. |
Enhanced amplifiability of minute fixative-treated tissue samples, minute stained cytology samples, and other minute sources of dna
|
|
US8609338B2
(en)
|
2006-02-28 |
2013-12-17 |
University Of Louisville Research Foundation, Inc. |
Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphisms
|
|
WO2007100911A2
(en)
|
2006-02-28 |
2007-09-07 |
University Of Louisville Research Foundation |
Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphisms
|
|
EP3892736A1
(en)
|
2007-07-23 |
2021-10-13 |
The Chinese University of Hong Kong |
Determining a nucleic acid sequence imbalance
|
|
US20100326218A1
(en)
|
2007-09-27 |
2010-12-30 |
Michael Boeckh |
Identifying a subject with an increased risk of invasive mold infection
|
|
WO2009064789A2
(en)
|
2007-11-15 |
2009-05-22 |
The Johns Hopkins University |
Methods for detecting and monitoring circulating cancer stem cells
|
|
GB2483810B
(en)
|
2008-11-07 |
2012-09-05 |
Sequenta Inc |
Methods for correlating clonotypes with diseases in a population
|
|
WO2010087985A2
(en)
|
2009-01-28 |
2010-08-05 |
Yale University |
Novel markers for detection of complications resulting from in utero encounters
|
|
WO2011015944A2
(en)
|
2009-08-06 |
2011-02-10 |
Cedars-Sinai Medical Center |
Use of free dna as an early predictor of severity in acute pancreatitis
|
|
JP2013509883A
(ja)
|
2009-11-06 |
2013-03-21 |
ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ |
臓器移植患者における移植片拒絶反応の非侵襲的診断方法
|
|
WO2011090556A1
(en)
|
2010-01-19 |
2011-07-28 |
Verinata Health, Inc. |
Methods for determining fraction of fetal nucleic acid in maternal samples
|
|
WO2011094646A1
(en)
|
2010-01-28 |
2011-08-04 |
Medical College Of Wisconsin, Inc. |
Methods and compositions for high yield, specific amplification
|
|
US20130071844A1
(en)
|
2010-03-24 |
2013-03-21 |
Toppan Printing Co., Ltd. |
Method for detecting target base sequence using competitive primer
|
|
US20120034603A1
(en)
|
2010-08-06 |
2012-02-09 |
Tandem Diagnostics, Inc. |
Ligation-based detection of genetic variants
|
|
US10131947B2
(en)
|
2011-01-25 |
2018-11-20 |
Ariosa Diagnostics, Inc. |
Noninvasive detection of fetal aneuploidy in egg donor pregnancies
|
|
BR112013020220B1
(pt)
|
2011-02-09 |
2020-03-17 |
Natera, Inc. |
Método para determinar o estado de ploidia de um cromossomo em um feto em gestação
|
|
US9290815B2
(en)
|
2011-02-21 |
2016-03-22 |
Qiagen Gmbh |
Method for quantifying human DNA
|
|
US20140199781A1
(en)
|
2011-03-08 |
2014-07-17 |
Beth Israel Deaconess Medical Center, Inc. |
Non-invasive methods for diagnosing chronic organ transplant rejection
|
|
UA115321C2
(uk)
|
2011-12-16 |
2017-10-25 |
Басф Агрокемікал Продактс Б.В. |
Спосіб та комплект для аналізу ahasl генів у рослин
|
|
WO2013159035A2
(en)
*
|
2012-04-19 |
2013-10-24 |
Medical College Of Wisconsin, Inc. |
Highly sensitive surveillance using detection of cell free dna
|
|
US10077474B2
(en)
|
2012-05-29 |
2018-09-18 |
Abbott Molecular, Inc. |
Method of designing primers, method of detecting single nucleotide polymorphisms (SNPs), method of distinguishing SNPs, and related primers, detectable oligonucleotides, and kits
|
|
NZ704039A
(en)
|
2012-08-03 |
2018-04-27 |
Ferring Bv |
Cell-free dna as a therapeutic target for female infertility and diagnostic marker
|
|
WO2014143989A1
(en)
|
2013-03-15 |
2014-09-18 |
Medical College Of Wisconsin, Inc. |
Fetal well being surveillance using fetal specific cell free dna
|
|
GB201304810D0
(en)
|
2013-03-15 |
2013-05-01 |
Isis Innovation |
Assay
|
|
SI3004388T2
(sl)
|
2013-05-29 |
2023-11-30 |
Chronix Biomedical |
Odkrivanje in kvantifikacija donorjeve brezcelične DNK v cirkulaciji prejemnikov presajenih organov
|
|
EP3968023B1
(en)
|
2013-08-19 |
2025-10-08 |
Invitae Corporation |
Assays for single molecule detection and use thereof
|
|
US20160376652A1
(en)
|
2013-09-06 |
2016-12-29 |
Immucor Gti Diagnostics, Inc. |
Compositions and methods for diagnosis and prediction of solid organ graft rejection
|
|
WO2015069933A1
(en)
|
2013-11-06 |
2015-05-14 |
The Board Of Trustees Of The Leland Stanford Junior University |
Circulating cell-free dna for diagnosis of transplant rejection
|
|
WO2015178978A2
(en)
|
2014-02-14 |
2015-11-26 |
The Board Of Regents Of The University Of Texas System |
Strand exchange hairpin primers that give high allelic discrimination
|
|
HUE043288T2
(hu)
|
2014-03-14 |
2019-08-28 |
Caredx Inc |
Eljárások immunszuppresszív terápiák monitorozására transzplantátum recipiensben
|
|
EP3134541B1
(en)
|
2014-04-21 |
2020-08-19 |
Natera, Inc. |
Detecting copy number variations (cnv) of chromosomal segments in cancer
|
|
EP3521454A1
(en)
|
2014-05-09 |
2019-08-07 |
LifeCodexx AG |
Detection of dna that originates from a specific cell-type and related methods
|
|
US10435750B2
(en)
|
2014-07-03 |
2019-10-08 |
Multiplicom N.V. |
Methods for non-invasive detection of transplant health or rejection
|
|
DK3194612T3
(da)
|
2014-08-22 |
2024-10-14 |
Resolution Bioscience Inc |
Fremgangsmåder til kvantitativ genetisk analyse af cellefrit dna
|
|
ES2708030T3
(es)
|
2014-10-20 |
2019-04-08 |
Inst Nat Sante Rech Med |
Métodos para explorar a un individuo en busca de un cáncer
|
|
WO2016109604A2
(en)
|
2014-12-29 |
2016-07-07 |
InnoGenomics Technologies, LLC |
Multiplexed assay for quantitating and assessing integrity of cell-free dna in biological fluids for cancer diagnosis, prognosis, and surveillance
|
|
WO2016123698A1
(en)
|
2015-02-06 |
2016-08-11 |
Uti Limited Partnership |
Diagnostic assay for post-transplant assessment of potential rejection of donor organs
|
|
US11318163B2
(en)
|
2015-02-18 |
2022-05-03 |
Enlivex Therapeutics Ltd |
Combination immune therapy and cytokine control therapy for cancer treatment
|
|
HK1252152A1
(zh)
*
|
2015-04-30 |
2019-05-17 |
Medical College Of Wisconsin, Inc. |
用於評估無細胞dna的多重優化錯配擴增(moma)實時pcr
|
|
CN108291330A
(zh)
|
2015-07-10 |
2018-07-17 |
西弗吉尼亚大学 |
卒中和卒中严重性的标志物
|
|
CA3001698C
(en)
|
2015-10-22 |
2025-01-07 |
Cytosorbents Corp |
Sorbant in the form of porous, blood-compatible polymer beads, multifunctional for the elimination of protein-based toxins and potassium from biological fluids
|
|
CA3007426A1
(en)
|
2015-12-03 |
2017-06-08 |
Alfred Health |
Monitoring treatment or progression of myeloma
|
|
AU2017258800A1
(en)
|
2016-04-29 |
2018-12-20 |
The Medical College Of Wisconsin, Inc. |
Multiplexed optimized mismatch amplification (MOMA)-real time PCR for assessing fetal well being
|
|
AU2017258799A1
(en)
|
2016-04-29 |
2018-12-20 |
The Medical College Of Wisconsin, Inc. |
Multiplexed optimized mismatch amplification (moma)-real time pcr for assessing cancer
|
|
EA201892489A1
(ru)
*
|
2016-04-29 |
2019-05-31 |
Дзе Медикал Колледж Оф Висконсин, Инк. |
Число мишеней для мультиплексной оптимизированной амплификации с несоответствиями (moma)
|
|
CA3042722A1
(en)
|
2016-11-02 |
2018-05-11 |
The Medical College Of Wisconsin, Inc. |
Methods for assessing risk using mismatch amplification and statistical methods
|
|
EP4488383A3
(en)
*
|
2016-11-02 |
2025-04-09 |
The Medical College of Wisconsin, Inc. |
Methods for assessing risk using total and specific cell-free dna
|
|
WO2018119422A1
(en)
|
2016-12-22 |
2018-06-28 |
Duke University |
Polycationic microfibers and methods of using the same
|
|
CA3067635A1
(en)
|
2017-06-20 |
2018-12-27 |
The Medical College Of Wisconsin, Inc. |
Transplant patient monitoring with cell-free dna
|
|
CN111094593A
(zh)
|
2017-06-20 |
2020-05-01 |
威斯康星州立大学医学院 |
使用供体特异性无细胞dna来评估移植对象中的病症
|
|
WO2019006561A1
(en)
|
2017-07-07 |
2019-01-10 |
Mcmaster University |
RISK ASSESSMENT TOOL FOR PATIENTS WITH SEPSIS
|
|
WO2019008408A1
(en)
|
2017-07-07 |
2019-01-10 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
METHODS FOR DETERMINING WHETHER A PATIENT SUFFERING FROM MYELOPROLIFERATIVE NEOPLASM IS AT RISK OF THROMBOSIS
|
|
AU2018332326B2
(en)
|
2017-09-18 |
2025-04-03 |
Santersus Ag |
Method and device for purification of blood from circulating cell free DNA
|
|
WO2019109053A1
(en)
|
2017-12-01 |
2019-06-06 |
Juno Therapeutics, Inc. |
Methods for dosing and for modulation of genetically engineered cells
|
|
US12084720B2
(en)
|
2017-12-14 |
2024-09-10 |
Natera, Inc. |
Assessing graft suitability for transplantation
|
|
WO2019217918A1
(en)
|
2018-05-10 |
2019-11-14 |
The Medical College Of Wisconsin, Inc. |
Multiplexed optimized mismatch amplification (moma)-cancer risk assessment with non-cancer associated targets
|
|
US20200109449A1
(en)
|
2018-10-09 |
2020-04-09 |
Tai Diagnostics, Inc. |
Cell lysis assay for cell-free dna analysis
|
|
WO2020131955A1
(en)
|
2018-12-17 |
2020-06-25 |
The Medical College Of Wisconsin, Inc. |
Assessing risk with total cell-free dna
|
|
WO2020206290A1
(en)
|
2019-04-03 |
2020-10-08 |
The Medical College Of Wisconsin, Inc. |
Methods for assessing risk using total cell-free dna
|
|
WO2020206269A1
(en)
|
2019-04-03 |
2020-10-08 |
The Medical College Of Wisconsin, Inc. |
Transplant patient monitoring with cell-free dna
|
|
WO2020206292A2
(en)
|
2019-04-03 |
2020-10-08 |
The Medical College Of Wisconsin, Inc. |
Assessing conditions in transplant subjects using donor-specific cell-free dna
|